Responding To Cybersecurity Threats: FDA Addresses Postmarket Questions In Draft Guidance
This article was originally published in The Gray Sheet
FDA issued a draft guidance on how companies should monitor and respond to potential cybersecurity threats in the postmarket setting. Some cybersecurity problems will require a recall action, but in most cases urgent notification to FDA will not be necessary, the document suggests.
Register for our free email digests: